543220 logo

Max Healthcare Institute Limited Stock Price

BSE:543220 Community·₹950.9b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

543220 Share Price Performance

₹977.05
-191.40 (-16.38%)
₹1,201.04
Fair Value
₹977.05
-191.40 (-16.38%)
18.6% undervalued intrinsic discount
₹1,201.04
Fair Value
Price ₹977.05
AnalystConsensusTarget ₹1,201.04
AnalystLowTarget ₹911.32
AnalystHighTarget ₹1,500.00

543220 Community Narratives

·
Fair Value ₹1.2k 18.6% undervalued intrinsic discount

Expanding Premium Healthcare In India Will Meet Rising Demand

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
·
Fair Value ₹911.32 7.2% overvalued intrinsic discount

Northern India Risks And Rising Capex Will Burden Future Operations

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value ₹1.5k 34.9% undervalued intrinsic discount

Rising Disposable Incomes And Aging Populations Will Drive Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
₹1.2k
18.6% undervalued intrinsic discount
Revenue
28.03% p.a.
Profit Margin
17.86%
Future PE
54.15x
Price in 2029
₹1.71k

Trending Discussion

Updated Narratives

543220 logo

543220: Kalinga Decision And Margin Outlook Will Shape Rich P E Concerns

Fair Value: ₹911.32 7.2% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
543220 logo

543220: Kalinga Hospital Acquisition Plans Will Support Continued Upside Ahead

Fair Value: ₹1.2k 18.6% undervalued intrinsic discount
9 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
543220 logo

543220: Upcoming Board Decisions On Expansion Will Support Stronger Long-Term Upside Potential

Fair Value: ₹1.5k 34.9% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential with solid track record.

0 Risks
2 Rewards

Max Healthcare Institute Limited Key Details

₹83.7b

Revenue

₹31.5b

Cost of Revenue

₹52.3b

Gross Profit

₹37.8b

Other Expenses

₹14.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
14.82
62.42%
17.23%
27.0%
View Full Analysis

About 543220

Founded
2001
Employees
15114
CEO
Abhay Soi
WebsiteView website
www.maxhealthcare.in

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Recent 543220 News & Updates

Narrative Update May 31

543220: Kalinga Decision And Margin Outlook Will Shape Rich P E Concerns

Analysts have inched up their price target on Max Healthcare Institute to ₹911 from ₹908, citing updated assumptions that combine more moderate revenue growth expectations with a higher profit margin outlook and a slightly lower future P/E multiple. What's in the News A board meeting is scheduled for May 21, 2026 to review standalone and consolidated results for the quarter and year ended March 31, 2026, consider a final dividend on equity shares, and review the re-appointment of cost auditors (company filing).

Recent updates

No updates

Max Healthcare Institute Limited Competitors